INTRODUCTION
Nucleobindin precursor protein, which was identified for the first time in the human and mouse cell lines, is known to have two isotypes, nucleobindin 1 (NUCB1) and nucleobindin 2 (NUCB2) (Miura et al., 1992; Kanai & Tanuma, 1992; Barnikol-Watanabe et al., 1994) . However, NUCB2 only functions physiologically in humans and rodents (Miura et al., 1992) . NUCB2 produces nesfatin-1 (residues 1-82), nesfatin-2 (residues 85-163), and nesfatin-3 (residues 166-396) by the enzyme pro-hormone convertase (PC)-1/3 after putative post-translational processing.
Until now, a physiological activity has only been demonstrated for nesfatin-1 (Oh-I et al., 2006; Stengel et al., 2012) . Nesfatin-1 is initially known to be expressed in the hypothalamic nuclei such as arcuate nucleus, paraventricular nucleus, supraoptic nucleus, lateral hypothalamic area and zona incerta in rats (Brailoiu et al., 2007; Chen et al., 2012; Foo et al., 2008; Fort et al., 2008; Goebel et al., 2009; Goebel et al., 2011; Kohno et al., 2008; Stengel et al., 2010; Xu et al., 2009) . Recent studies showed that a large amount of the nesfatin-1 expression was detected in the digestive system as well as in the brain. It has also been reported that the nesfatin-1 generated in the gastric organs, by acting in the brain, reduces food intake and suppresses the motilities of the stomach-duodenum (Prinz et al., 2016; Jiang et al., 2016) . Nesfatin-1 immunoreactive cells are also co-localized with insulin in pancreatic beta-cells of mice and rats, suggesting a potential role for nesfatin-1 in pancreatic islet and glucose homeostasis (Shimizu & Osaki, 2014; Gonzalez et al., 2009) . Furthermore, nesfatin-1 was detected in the adipose tissues of humans and rodents, showing that it was expressed more in the subcutaneous than in the visceral fat (Shimizu et al., 2016) .
Recent studies have demonstrated that nesfatin-1/ NU-CB2 are expressed in the reproductive system (GarciaGaliano et al., 2010) . We have also been shown that nesfatin-1/ NUCB2 mRNA and protein are expressed in the mouse hypothalamus and pituitary and its expression levels were regulated by the gonadotropin (Kim et al., 2014; Chung et al., 2015) . Moreover, we showed that the expression of nesfatin-1/NUCB2 in the pituitary and hypothalamus is regulated by estradiol and progesterone secreted by the ovary (Chung et al., 2015) . Therefore, we investigated whether the expression of nesfatin-1/NUCB2 in the pituitary and hypothalamus is affected by the testosterone produced by the testis in the male mouse.
MATERIALS AND METHODS

Animal
Eight-week-old male ICR mice were purchased from KOATECH (South Korea) and housed in groups of five per cage under controlled illumination (12:12 h light/dark cycle, lights on/off: 6 h/18 h) and temperature (22±2℃).
Animals were fed a standard rodent diet and tap water ad libitum. Animal care and experimental procedures were approved by the Institutional Animal care and the use committee at the Seoul Women's University in accordance with guidelines established by the Korea Food and Drug Administration.
Testosterone treatment
Mice were castrated and rested for 48 h followed by intraperitoneal injection (100 μL/mouse) subcutaneously with sesame oil alone and with testosterone (300 ng/100 μL; Sigma, St. Louis, MO) dissolved in sesame oil. Mice were euthanized by CO 2 anesthesia followed by cervical dislocation, and then the cerebrum, hypothalamus, pituitary gland, and stomach were collected 24 h after treatment. We , and 10 --6 M testosterone (Sigma, St. Louis, MO) for 24 h.
RNA extraction and cDNA synthesis
The cerebrum, hypothalamus, pituitary gland, and stomach were homogenized with RNA isoplus (TaKaRa Bio, Shiga, Japan). After chloroform extraction and isopropyl alcohol precipitation, RNA was dissolved in RNase-free 
Statistical Analysis
The results were presented as the mean and the standard error of the mean(SEM). Data were analyzed by ANOVA and student t-test. Values of p<0.05 were considered significant. All data are represented as mean±SEM.
RESULTS
1. Expression of nesfatin-1/NUCB2 in the hypothalamus and pituitary gland of male mouse NUCB2 mRNA expression in the cerebrum, hypothalamus, pituitary, and stomach was detected by conventional PCR and qRT-PCR. We found that the NUCB2 gene was expressed in all tissues and its mRNA expression was significantly higher in the pituitary gland than in the cerebrum, hypothalamus, and stomach ( Fig. 1A and C) . Western blots confirmed that, similar to NUCB2 mRNA expression, nesfatin-1/NUCB2 protein was highly expressed in the pituitary gland (Fig. 1B) . Immunohistochemical staining The NUCB2 mRNA was significantly higher in the pituitary than in the other tissues.
showed that nesfatin-1/NUCB2 protein was localized in many cells within the anterior pituitary gland (Fig. 2) .
NUCB2 mRNA expression in the hypothalamus and pituitary gland after testosterone injection
To assess whether NUCB2 mRNA expression in the hypothalamus and pituitary gland was regulated by testosterone secreted by the testis, mice were castrated and injected with testosterone. The expression of NUCB2 mRNA in the hypothalamus was not changed after castration, but its expression was significantly decreased after injection with testosterone (Fig. 3A) . In the pituitary gland, the expression of NUCB2 mRNA was significantly decreased after castration and increased after injection with testosterone ( Fig. 3B) . (Fig. 4A) . By contrast, NUCB2 mRNA expression in the pituitary gland was increased in dose-dependent manner, showing significant increase in 10 −6 M testosterone treatment (Fig. 4B ).
DISCUSSION
Nesfatin-1 protein produced by neurons in the hypothalamus is known to be secreted into cerebrospinal fluid, and be controlling of appetite and energy metabolism (Oh-I et al., 2006) . Recently, it has been reported that nesfatin-1/NUCB2 mRNA is expressed in gastric organs such as stomach and pancreas , in adipose tissues of humans and rodents (Garcia-Galiano et al., 2010) and in the male and female mouse reproductive organs (Kim et al., 2010; Kim et al., 2011) . Our previous study has demonstrated that nesfatin-1/NUCB2 expression level is higher in the pituitary gland compared to other organs and its expression is regulated by 17β-estradiol and progesterone secreted from the ovary (Chung et al., 2015) .
However, currently no data exist on the expression of nesfatin-1/NUCB2 and its regulation mechanism in the pituitary of male mouse. Therefore, in the present study we examined whether nesfatin-1/NUCB2 is present in the male mouse pituitary and if its expression is regulated by testosterone.
To examine the relative expression of nesfatin-1/NU-CB2 mRNA and protein in the pituitary, we performed conventional PCR using total RNA extracted from the cerebrum, hypothalamus, pituitary, and stomach. The conventional PCR analysis showed that NUCB2 mRNA expression is detected in all tissues. The qRT-PCR and Western blotting data showed that the expression of nesfatin-1 pro-tein and NUCB2 mRNA were higher in the pituitary gland than in other tissues. It is well known that nesfatin-1/ NUCB2 mRNA is abundantly expressed in the hypothalamus (Oh-I et al., 2006) . Furthermore, recent reports have shown that nesfatin-1/NUCB2 is also expressed in the pituitary (Foo et al., 2008) . These results raise the possibility that nesfatin-1 produced in the brain may control the meta- terone has been known to influence appetite control and feeding behavior (Iwasa et al., 2016; Bautista et al., 2012) .
Hypothalamic mRNA levels of ERα, which plays pivotal roles in regulation of body weight and metabolism, were decreased by chronic testosterone administration in rats (Iwasa et al., 2016) . In female rats following ovariectomy, a stabilization of food intake was not observed, but energy intake was increased. By contrast, castration in males induced loss of body weight, whereas castrated males given testosterone showed complete restoration of eating activity (Ferreira et al., 2012) . We also have previously reported that NUCB2 expression in the pituitary gland of female mice was dramatically decreased after ovariectomy and increased with injection of progesterone and estradiol, respectively. Furthermore, the in vitro experiment to elucidate the direct effect of progesterone and estradiol on NUCB2 mRNA expression showed NUCB2 mRNA expression was significantly increased with estradiol and decreased with progesterone alone and progesterone and estradiol in cultured pituitary tissue (Chung et al., 2015) .
The present study demonstrated that nesfatin-1/NUCB2
was highly expressed in the mouse pituitary and was regulated by testosterone. Recently, it is reported that nesfatin-1 production is greater in the reproductive organs, such as the seminal gland, testis, uterus, and ovary in rats with metabolic syndrome (Kim et al., 2010; Kim et al., 2011; Kim et al., 2014) . These results suggest that metabolic syndrome could also influence the nesfatin-1/NUCB2 expression in the pituitary gland regulating appetite and energy homeostasis. Estradiol has been known to inhibit feeding in rats with a reduction of food intake around the time of ovulation, when estradiol presents its highest levels.
NUCB2 Expression in Male Mouse Hypothalamus and Pituitary Gland
Men with higher testosterone levels compared to women accumulate more fat in the intraabdominal depot, suggesting that testosterone stimulates feeding (Bautista et al., 2012 ).
was expressed in the hypothalamus and pituitary gland of male mouse and its mRNA expression in the hypothalamus and pituitary gland was regulated by testosterone. This data suggests that reproductive-endocrine regulation through hypothalamus-pituitary-testis axis may contribute to nesfatin-1/NUCB2 expression in the hypothalamus and pituitary gland.
